Clinical Trial Update: Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating AP707 for chronic pain due to central neuropathy; efficacy and tolerability data are not yet fully disclosed in the provided u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Neuropathic Pain
• Multiple Sclerosis
• Neuropathic Pain
• Pain
• Pain Chronic
• Pain Syndrome
• Paraplegia
• Phantom Limb Pain
• Phantom Pain
• Stroke
• Traumatic Brain Injury

Drugs mentioned

• AP707

Snippet

Sponsor: Apurano Pharmaceuticals GmbH | Conditions: Pain, Pain Syndrome | Phase 3 | Status: UNKNOWN